美国阿纳海姆消息:组织型纤维蛋白溶酶原激活剂(t-PA)可有效地治疗急性出血性脑栓塞。辛辛那提大学Thomas Brott指出,迄今尚未发现由于使用t-PA所致的并发症。在输入t-PA的14名病人中,5人的临床症状有改善。适于t-PA治疗的病人是,CT检查结果必须无局部性缺血,有感觉丧失或共济失调。最重要的条件是出现症状后90分钟内必须输入t-PA,比心肌梗塞时 Anaheim, USA: Tissue-type plasminogen activator (t-PA) is effective in the treatment of acute hemorrhagic cerebral embolism. Thomas Brott of the University of Cincinnati pointed out that so far no complications due to the use of t-PA have been found. Of the 14 patients who entered t-PA, five had improved clinical symptoms. Patients eligible for t-PA therapy should have no local ischemia, loss of sensation, or ataxia on CT findings. The most important condition is that you must enter t-PA 90 minutes after the onset of symptoms, compared with myocardial infarction